# Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders

> **NCT04064944** · PHASE2 · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 144 (estimated)

## Conditions studied

- Neuromyelitis Optica Spectrum Disorder

## Interventions

- **DEVICE:** blood purification equipment

## Key facts

- **NCT ID:** NCT04064944
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2023-08-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2019-08-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04064944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04064944, "Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04064944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*